Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
For now, Lilly and Novo remain favored providers of obesity drugs due to their leading brands and manufacturing capacities
Overconsumption of readily available, nutrient-rich foods has created an environment of overnutrition, leading to health issues like obesity and metabolic syndrome
Daily Injections Weekly injectables include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), tirzepatide (Mounjaro, Zepbound) and exenatide extended release (Bydureon BCise)
Urbina et al
Agarwal et al., 2008
US$ 25.10
US$ 23.56
US$ 28.70
US$ 24.15
US$ 29.34
US$ 25.36
US$ 26.58
US$ 20.40
US$ 26.49
US$ 20.70
US$ 26.00
US$ 21.98
